Lumos Pharma Inc reports results for the quarter ended in June - Earnings Summary

Lumos Pharma

05/08/2021 15:10

* Lumos Pharma Inc  LUMO.OQ  reported a quarterly adjusted loss
of $1.04​​ per share for the quarter ended in June. The mean
expectation of six analysts for the quarter was for a loss of
$1.03 per share.
* Revenue fell 69.7% to $10.00 thousand from a year ago; 
analysts expected zero. 
* Lumos Pharma Inc's reported EPS for the quarter was a loss of
$1.04​.
* The mean earnings estimate of analysts had fallen by
about 1.6% in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Lumos Pharma Inc shares had fallen by 25.0% this quarter and
lost 79.0% so far this year.
* The company reported a quarterly loss of $8.67 million.
* Wall Street's median 12-month price target for Lumos Pharma
Inc is $29.50 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 5 at 02:10 p.m.  ​All
figures in US dollars unless otherwise stated